Medical cannabis is to be available on prescription in the UK after being approved for use by the government.

Home Secretary Sajid Javid, said:

“Recent cases involving sick children made it clear to me that our position on cannabis-related medicinal products was not satisfactory. 

“Following advice from two sets of independent advisers, I have taken the decision to reschedule cannabis-derived medicinal products – meaning they will be available on prescription.

“This will help patients with an exceptional clinical need.”

A Populus survey conducted earlier this year unveiled overwhelming support for the legalisation of cannabis for medical use only. The survey, conducted on the Populus MP Panel of 109 MPs found that a majority (61%) support the legalisation of cannabis for medical use only.

The survey of MPs was conducted in March 2018. It shows that a relaxation of the law surrounding the use of cannabis for medical use is likely to have widespread support in the House of Commons.

Indeed, 71% of Labour MPs and 50% of Conservative MPs support legalisation for medical use suggesting cross-party support.

Several politicians have recently voiced their support for reform of the UK’s drug laws.

The public also seems to be supportive of a review, with 78% telling Populus in 2016 that they support the legalisation of cannabis for medical use, prescribed where appropriate by GPs and hospitals.

Support for the legalisation of cannabis for recreational use is lower than for medical use amongst the public but not inconsiderable.

A third (34%) of the public support the legalisation of cannabis for recreational use, though 58% oppose it. Support is very low, however, in the House of Commons; just 12% of MPs (though rising to 17% of Labour MPs) support the legalisation for recreational use according to the Populus’s research in March 2018.

The Populus MP Panel surveys 250 MPs, both frontbenchers and backbenchers, from all main political parties. It enables businesses in all sectors to measure what key stakeholder audiences think of major issues that confront their industry, explore the attitudes of these influential groups towards the issues that companies face, and test the effectiveness of key messages. Find out more about the Populus MP Panel here.

Methodology

Populus interviewed 109 MPs in March 2018 online or by self-completion postal questionnaire. Results were weighted in order to ensure the sample was representative of the party composition of the House of Commons.

Populus also interviewed 4,048 adults in Great Britain online between 28 September and 2 October 2016. Results were weighted in order to ensure the sample was demographically representative of the adult population in Great Britain.

Populus is a member of the British Polling Council and abides by its rules. For more information, see www.populus.co.uk